Quick Answer
SpyGlass Pharma, Inc. reported R&D Expense of $29.18 million for fiscal year 2025.
SpyGlass Pharma, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $29.18M | +46.0% |
| 2024 | $19.98M | — |
- SpyGlass Pharma, Inc. showed an increase of +46.0% in R&D Expense compared to the prior fiscal year.
- Over the 2024–2025 period, SpyGlass Pharma, Inc.’s r&d expense has grown by 46.0% (from $19.98 million to $29.18 million).
- The most recent figure is from SpyGlass Pharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: